UPSC Mains practice: TB bottlenecks and PLI scheme examined

The Story in Brief

The Indian Express, through its UPSC Essentials initiative, has published GS-3 answer-writing practice questions for Tuesday, 17 November 2026. The first question asks candidates to examine key bottlenecks in India’s fight to eliminate tuberculosis, noting that despite diagnostic and treatment improvements, structural, socioeconomic, and healthcare delivery barriers persist. The second question calls for a discussion on the role of Production-Linked Incentive schemes in strengthening manufacturing capabilities and integrating India into global value chains.

UPSC Mains practice: TB bottlenecks and PLI scheme examined

The TB question highlights that India accounts for roughly a quarter of the global TB burden and had set a 2025 elimination target, five years ahead of the global deadline. Key bottlenecks listed include limited access to rapid molecular testing in rural areas, a lack of current national incidence estimates due to a delayed India TB Report, a high burden of drug-resistant TB, treatment abandonment due to socioeconomic challenges, and inadequate standardisation in private healthcare. The article notes that district-level sentinel surveillance in 2025 is now being reviewed, but the absence of updated data hampers resource allocation.

The answer guidance does not provide model answers but offers a thought process for aspirants. It emphasises that elimination requires going beyond case detection to include disease prevention, nutritional security, and improved healthcare delivery through the National TB Elimination Program.

Indian Opinion Analysis

The UPSC Mains practice set for GS-3 highlights a major public health data gap: India’s own TB Report has been delayed, and district-level prevalence figures from 2025 sentinel surveillance remain unreleased, hampering resource allocation and monitoring of elimination targets. This lack of granular data affects district-level planning and leaves policymakers without a baseline to measure whether India has closed the gap on its own 2025 elimination deadline, which it has already missed. The questions also point to systemic bottlenecks, undernutrition, drug-resistant TB, and private-sector fragmentation, that no single diagnostic or drug can fix. Upcoming issues of the India TB Report and the release of the 2025 prevalence data will be critical to determine whether India is on track for a revised elimination timeline.


Source: indianexpress.com

This brief was synthesised by AI from the source linked above. Methodology and corrections.

Ask their opinion on this story
They have read this article, our coverage, and the web.
AI simulations of historical figures. Responses are generated from the historical record, not authentic statements.

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Share your opinion

Sign in to comment

Comments are open to readers with an Indian Opinion account. We email you a 6-digit code; there is no password.

Sign in to comment

Loading Next Post...
Search Trending
Ask their opinion
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

All fields are required.